- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00829660
Acarbose Cardiovascular Evaluation Trial (ACE)
2017년 7월 21일 업데이트: University of Oxford
A Long-term, Multicentre, Double-blind, Randomised Parallel-group Trial to Determine Whether Reducing Post-prandial Glycaemia Can Reduce Cardiovascular-related Morbidity and Mortality in Patients With Established Coronary Heart Disease or Acute Coronary Syndrome Who Have Impaired Glucose Tolerance
The purpose of this study is to determine whether acarbose therapy can reduce cardiovascular-related morbidity and mortality in patients with impaired glucose tolerance (IGT) who have established coronary heart disease (CHD) or acute coronary syndrome (ACS).
A secondary objective of the study is to determine if acarbose therapy can prevent or delay transition to type 2 diabetes mellitus (T2DM) in this patient population.
연구 개요
상세 설명
A long-term, multicentre, double-blind, randomised parallel-group trial to determine whether reducing post-prandial glycaemia can reduce cardiovascular-related morbidity and mortality in patients with established coronary heart disease or acute coronary syndrome who have impaired glucose tolerance.
연구 유형
중재적
등록 (실제)
6526
단계
- 4단계
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
Anhui
-
Hefei, Anhui, 중국, 230032
- The First Affiliated Hospital of Anhui Medical University
-
-
Beijing
-
Beijing, Beijing, 중국, 100034
- Peking University First Hospital
-
Beijing, Beijing, 중국, 100730
- Peking Union Medical College Hospital
-
Beijing, Beijing, 중국, 100053
- Xuanwu Hospital Capital Medical University
-
Beijing, Beijing, 중국, 100044
- Peking University People's Hospital
-
Beijing, Beijing, 중국, 100853
- PLA General Hospital
-
Beijing, Beijing, 중국, 100029
- China-Japan Friendship Hospital
-
Beijing, Beijing, 중국, 100028
- China Meitan General Hospital
-
Beijing, Beijing, 중국, 100038
- Beijing Shijitan Hospital
-
Beijing, Beijing, 중국, 100038
- Fu Xing Hospital
-
Beijing, Beijing, 중국, 100035
- Beijing Ji Shui Tan Hospital
-
Beijing, Beijing, 중국, 100022
- Beijing Chuiyangliu Hospital
-
Beijing, Beijing, 중국, 100029
- Beijing Anzhen Hospital of the Capital University of Medical Sciences
-
Beijing, Beijing, 중국, 100043
- Beijing Shijingshan Hospital
-
Beijing, Beijing, 중국, 100049
- Aerospace central hospital
-
Beijing, Beijing, 중국, 100050
- Affiliated to The Capital University of Medical Sciences Beijing Friendship Hospital
-
Beijing, Beijing, 중국, 100053
- Wangjing Hospital of CACMS
-
Beijing, Beijing, 중국, 100054
- Beijing Healthy Palace Hospital
-
Beijing, Beijing, 중국, 100074
- Aerospace 731 Hospital
-
Beijing, Beijing, 중국, 100088
- General Hospital of Second Artillery PLA
-
Beijing, Beijing, 중국, 101200
- Anzhen Hospital of The Capital University of Medical Sciences 2nd.
-
Beijing, Beijing, 중국, 101200
- Beijing Pinggu Hospital
-
Beijing, Beijing, 중국, 102500
- Beijing Yanhua Hospital
-
-
Chongqing
-
Chongqing, Chongqing, 중국, 400016
- The First Affiliated Hospital of Chongqing Medical University
-
Chongqing, Chongqing, 중국, 400010
- Chongqing Medical University Second Afflicated Hospital
-
Chongqing, Chongqing, 중국, 400013
- Chongqing Zhongshan Hospital
-
Chongqing, Chongqing, 중국, 400014
- Chongqing Third People's Hospital
-
Chongqing, Chongqing, 중국, 400042
- Da Ping Hospital
-
Chongqing, Chongqing, 중국, 402160
- The Second People's Hospital of Chongqing
-
-
Fujian
-
Fuzhou, Fujian, 중국, 350001
- Fujian Provincial Hospital
-
Fuzhou, Fujian, 중국, 350001
- Union Hospital Affiliated to Fujian Medical University
-
Fuzhou, Fujian, 중국, 350004
- The People's Hospital of Fujian Province
-
Xiamen, Fujian, 중국, 361004
- Zhongshan Hospital Xiamen University
-
Xiamen, Fujian, 중국, 361003
- The First Hospital of Xiamen
-
-
Guangdong
-
Guangzhou, Guangdong, 중국, 510080
- The First Affiliated Hospital of Sun Yat-Sen University
-
Guangzhou, Guangdong, 중국, 510120
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
-
Guangzhou, Guangdong, 중국, 510080
- Guangdong General Hospital
-
Guangzhou, Guangdong, 중국, 510630
- The First Affiliated Hospital of Jinan University
-
Guangzhou, Guangdong, 중국, 510150
- The Third Affiliated Hospital of Guangzhou Medical College
-
Guangzhou, Guangdong, 중국, 510080
- The First Affiliated Hospital of Guangdong Pharmaceutical University
-
Guangzhou, Guangdong, 중국, 510507
- Wu Jing Zhong Dui Hospital of Guangdong Province
-
Shenzhen, Guangdong, 중국, 518036
- Peking University Shenzhen Hospital
-
Zhongshan, Guangdong, 중국, 528403
- Zhong Shan City People's Hospital
-
Zhuhai, Guangdong, 중국, 519000
- The Fifth Affiliated Hospital of Sun Yat-sen University
-
-
Guangxi
-
Liuzhou, Guangxi, 중국, 545005
- Liuzhou Worker's Hospital
-
Liuzhou, Guangxi, 중국, 545006
- Liuzhou people's Hospital
-
Nanning, Guangxi, 중국, 530021
- The First Affiliated Hospital of Guangxi Medical University
-
Nanning, Guangxi, 중국, 530001
- Minzu Hospital of Guangxi Zhuang Autonomous Region
-
Nanning, Guangxi, 중국, 530021
- 303 Hospital of People's Liberation Army
-
-
Guizhou
-
Guiyang, Guizhou, 중국, 550004
- The affiliated Hospital of Guiyang Medical College
-
-
Hebei
-
Cangzhou, Hebei, 중국, 062650
- Cangzhou Central Hospital
-
Shijiazhuang, Hebei, 중국, 050000
- The Second Hospital of Hebei Medical University
-
Shijiazhuang, Hebei, 중국, 050031
- The First Hospital of Hebei Medical University
-
Shijiazhuang, Hebei, 중국, 050082
- Bethune International Peace Hospital
-
Tangshan, Hebei, 중국, 063000
- Tangshan Workers Hospital
-
Tangshan, Hebei, 중국, 063000
- The Affiliated Hospital of North China Coal Medical University
-
Tangshan, Hebei, 중국, 064100
- Yu Tian County Hospital
-
Zhangjiakou, Hebei, 중국, 075000
- The Third Affiliated Hospital of Hebei North University
-
-
Heilongjiang
-
Da Qing, Heilongjiang, 중국, 163001
- Da Qing Oilfield General Hospital
-
Harbin, Heilongjiang, 중국, 150001
- The Fourth Affiliated Hospital of Harbin Medical University
-
-
Henan
-
Luoyang, Henan, 중국, 471003
- The First Affiliated Hospital of Henan Science & Technology University
-
Luoyang, Henan, 중국, 471009
- Luo Yang Central Hospital, Affiliated to Zhengzhou University
-
ZhengZhou, Henan, 중국, 450014
- The Second Affiliated Hospital of Zhengzhou University
-
Zhengzhou, Henan, 중국, 450000
- The First Affiliated Hospital of Henan College of TCM
-
Zhengzhou, Henan, 중국, 450003
- The People's Hospital of Zhengzhou
-
-
Hubei
-
Wuhan, Hubei, 중국, 430071
- Zhongnan Hospital of Wuhan University
-
Wuhan, Hubei, 중국, 430060
- Renmin Hospital of Wuhan University
-
Wuhan, Hubei, 중국, 430022
- Wuhan Asia Heart Hospital
-
Wuhan, Hubei, 중국, 430022
- Union Hospital of Tongji Medical College of Huazhong
-
Wuhan, Hubei, 중국, 430030
- Tongji Hospital of Tongji Medical College of Huazhong
-
Wuhan, Hubei, 중국, 430033
- Pu'ai Hospital of Wuhan City
-
-
Hunan
-
Changsha, Hunan, 중국, 410008
- Xiangya Hospital Central-South University
-
Changsha, Hunan, 중국, 410015
- The Third Hospital of Changsha
-
Changsha, Hunan, 중국, 410005
- Hunan Provincial People's Hospital
-
Changsha, Hunan, 중국, 410006
- The Fourth Hospital of Changsha
-
-
Inner Mongolia
-
Baotou, Inner Mongolia, 중국, 014010
- The First Affiliated Hospital of Baotou Medical College
-
Baotou, Inner Mongolia, 중국, 014040
- Baotou Central Hospital
-
Chifeng, Inner Mongolia, 중국, 024000
- Chifeng Municipal Hospital
-
Hohhot, Inner Mongolia, 중국, 010017
- Inner Mongolia Hospital
-
-
Jiangsu
-
NanJing, Jiangsu, 중국, 210002
- 81st Hospital of Chinese PLA
-
NanJing, Jiangsu, 중국, 210024
- Jiangsu Province Official Hospital
-
NanJing, Jiangsu, 중국, 210029
- Jiangsu Provincial Hospital of TCM
-
Nanjing, Jiangsu, 중국, 210008
- Nanjing Drum Tower Hospital
-
Nanjing, Jiangsu, 중국, 210029
- Jiangsu Province Hospital
-
Nanjing, Jiangsu, 중국, 210006
- Nanjing First Hospital
-
Nanjing, Jiangsu, 중국, 211100
- Nanjing Jiangning Hospital
-
Nanjing, Jiangsu, 중국, 210009
- Nanjing Zhongda Hospital
-
Nanjing, Jiangsu, 중국, 210017
- BenQ Hospital
-
Suzhou, Jiangsu, 중국, 215000
- Suzhou Municipal Hospital
-
Wuxi, Jiangsu, 중국, 214023
- Wuxi People's Hospital
-
Wuxi, Jiangsu, 중국, 214002
- Wuxi No.2 People's Hospital
-
Wuxi, Jiangsu, 중국, 214041
- Wuxi No.3 People's Hospital
-
Xuzhou, Jiangsu, 중국, 221000
- Hospital Affiliated Xuzhou Medical University
-
Xuzhou, Jiangsu, 중국, 221006
- The Second Affiliated Hospital Of Xuzhou Medical University
-
Zhenjiang, Jiangsu, 중국, 212002
- Zhenjiang First People's Hospital
-
-
Jiangxi
-
Jiujiang, Jiangxi, 중국, 332000
- Jiujiang University Hospital
-
Nanchang, Jiangxi, 중국, 330006
- The Second Affiliated Hospital of Nanchang University
-
Nanchang, Jiangxi, 중국, 330006
- Jiangxi Provincial People's Hospital
-
Nanchang, Jiangxi, 중국, 330008
- The Third Affiliated Hospital of Nanchang University
-
-
Jilin
-
Changchun, Jilin, 중국, 130033
- China-Japan Union Hospital of Jilin University
-
Changchun, Jilin, 중국, 130041
- The Second Hospital of Jilin University
-
-
Liaoning
-
Anshan, Liaoning, 중국, 114001
- The Central Hospital of Anshan
-
Dalian, Liaoning, 중국, 116011
- The First Hospital of Dalian Medical University
-
Dalian, Liaoning, 중국, 116001
- Affiliated Zhongshan Hospital of Dalian University
-
Dalian, Liaoning, 중국, 116033
- Dalian Central Hospital
-
Shengyang, Liaoning, 중국, 712000
- Xianyang Central Hospital
-
Shenyang, Liaoning, 중국, 110016
- The People's Hospital of Liaoning Province
-
Shenyang, Liaoning, 중국, 110004
- Shengjing Hospital Of China Medical University
-
Shenyang, Liaoning, 중국, 110021
- Shengjing Hospital Of China Medical University
-
Shenyang, Liaoning, 중국, 110032
- The Fourth Hospital of China Medical University
-
-
Ningxia
-
Yinchuan, Ningxia, 중국, 750004
- Affiliated Hospital of Ningxia Medical University
-
Yinchuan, Ningxia, 중국, 750001
- The First Hospital of Yinchuan
-
Yinchuan, Ningxia, 중국, 750021
- The People's Hospital of Ningxia Hui Autonomous Region
-
-
Shaanxi
-
Xi'an, Shaanxi, 중국, 710061
- The First Affiliated Hospital of Xi'an Jiaotong University
-
Xi'an, Shaanxi, 중국, 710003
- Xi'an Central Hospital
-
Xi'an, Shaanxi, 중국, 710077
- Affiliated Hospital of Xi'an Medical college
-
Yan'an, Shaanxi, 중국, 716000
- Affiliated Hospital of Yan'an University
-
Yanan, Shaanxi, 중국, 716000
- Yan'an People's Hospital
-
Yulin, Shaanxi, 중국, 719000
- The first hospital of yulin
-
-
Shandong
-
Jinan, Shandong, 중국, 250013
- The Central Hospital of Jinan
-
Jinan, Shandong, 중국, 250013
- The First People's Hospital of Jinan
-
Jinan, Shandong, 중국, 250031
- The General Hospital of Jinan Military Region
-
Linyi, Shandong, 중국, 276003
- Linyi People's Hospital
-
Qingdao, Shandong, 중국, 266003
- Hospital Affiliated of Medical School, Qingdao University
-
Qingdao, Shandong, 중국, 266011
- The Qingdao Municiple Hospital
-
Shibei, Shandong, 중국, 266034
- Qingdao Fuwai Hospital
-
Taian, Shandong, 중국, 271000
- Taian City Central Hospital
-
-
Shanghai
-
Shanghai, Shanghai, 중국, 200433
- Changhai Hospital
-
Shanghai, Shanghai, 중국, 200120
- Shanghai East Hospital
-
Shanghai, Shanghai, 중국, 200011
- Shanghai Ninth People's Hospital
-
Shanghai, Shanghai, 중국, 200092
- Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
-
Shanghai, Shanghai, 중국, 200072
- Shanghai Tenth People's Hospital
-
Shanghai, Shanghai, 중국, 200032
- Shanghai Zhongshan Hospital
-
Shanghai, Shanghai, 중국, 200065
- Tongji Hospital of Tongji University
-
Shanghai, Shanghai, 중국, 200135
- Shanghai Pudong New Area Gongli Hospital
-
Shanghai, Shanghai, 중국, 200025
- Ruijin Hospital Affiliated to the Shanghai Jiaotong University Medical School
-
Shanghai, Shanghai, 중국, 200031
- Shanghai Central Hospital of Xuhui District
-
Shanghai, Shanghai, 중국, 200040
- ShangHai Huadong Hospital
-
Shanghai, Shanghai, 중국, 200060
- Shanghai Putuo District People's Hospital
-
Shanghai, Shanghai, 중국, 200062
- Putuo District Center Hospital
-
Shanghai, Shanghai, 중국, 200081
- Number 411 Hospital of PLA
-
Shanghai, Shanghai, 중국, 200090
- Shanghai Central Hospital of Yangpu District
-
Shanghai, Shanghai, 중국, 200127
- Renji Hospital Affilicated to Jiaotong University School of Medicine
-
Shanghai, Shanghai, 중국, 200435
- Shanghai Zhabei District Shibei Hospital
-
Shanghai, Shanghai, 중국, 200540
- Shanghai Jinshan Hospital
-
Shanghai, Shanghai, 중국, 201200
- Shanghai Pudong New District People's Hospital
-
-
Shanxi
-
Taiyuan, Shanxi, 중국, 030024
- Shanxi Cardiovascular Hospital
-
Taiyuan, Shanxi, 중국, 030003
- General Hospital of TISCO
-
Taiyuan, Shanxi, 중국, 030006
- The Third Engineering Bureau Hospital of Ministry of Railway
-
Taiyuan, Shanxi, 중국, 030009
- Taiyuan City Central Hospital
-
Xi'an, Shanxi, 중국, 710054
- PLA No.323 Hospital
-
-
Sichuan
-
Chengdu, Sichuan, 중국, 610017
- Chengdu Second People's Hospital
-
Chengdu, Sichuan, 중국, 610016
- Chengdu First People's Hospital
-
Chengdu, Sichuan, 중국, 610041
- Sichuan Provincial People's Hospital
-
Chengdu, Sichuan, 중국, 610041
- The West China Hospital
-
Sichuan, Sichuan, 중국, 621000
- Sichuan Mianyang 404 Hospital
-
-
Tianjin
-
Tianjin, Tianjin, 중국, 300051
- Tianjin Chest Hospital
-
Tianjin, Tianjin, 중국, 300170
- Tianjin Third Central Hospital
-
Tianjin, Tianjin, 중국, 300211
- The Second Hospital Of Tianjin Medical University
-
Tianjin, Tianjin, 중국, 300192
- Tianjin First Center Hospital
-
Tianjin, Tianjin, 중국, 300050
- Tianjin Union Hospital
-
Tianjin, Tianjin, 중국, 300121
- Tianjin Union Medicine Centre
-
Tianjin, Tianjin, 중국, 300162
- Army Police's Medical College Affiliated Hospital
-
Tianjin, Tianjin, 중국, 300280
- Dagang Oil-Field General Hospital
-
Tianjin, Tianjin, 중국, 300450
- The Fifth Central Hospital of Tianjin
-
-
Xinjiang
-
Shihezi, Xinjiang, 중국, 832008
- First Affiliated Hospital of the Medical College
-
Urumqi, Xinjiang, 중국, 830054
- The First Teaching Hospital of Xinjiang Medical University
-
Urumqi, Xinjiang, 중국, 830000
- Xin Jiang Traditional Chinese Medicine Hospital
-
Urumqi, Xinjiang, 중국, 830002
- General Hospital of Xinjiang Production and Construction Corps
-
Urumqi, Xinjiang, 중국, 830013
- The 474th Hospital of PLA
-
-
Yunnan
-
Kunming, Yunnan, 중국, 650032
- The First Affiliated Hospital of Kunming Medical College
-
Kunming, Yunnan, 중국, 650032
- The First People's Hospital of Yunnan Province
-
Kunming, Yunnan, 중국, 650101
- The Second Affiliated Hospital of Kunming Medical College
-
Yuxi, Yunnan, 중국, 653100
- People's Hospital of Yuxi City
-
-
Zhejiang
-
Hangzhou, Zhejiang, 중국, 310013
- Zhe Jiang Hospital
-
Hangzhou, Zhejiang, 중국, 310016
- Sir Run Run Shaw Hospital Affiliated With School of Medicine, Zhe Jiang University
-
-
-
-
-
Hong Kong, 홍콩
- Prince of Wales Hospital
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
50년 이상 (성인, 고령자)
건강한 자원 봉사자를 받아들입니다
아니
연구 대상 성별
모두
설명
Inclusion Criteria:
- Male or female, aged 50 years or more.
Definite CHD, defined as a, b or c below:
Previous myocardial infarction (MI) or Acute Coronary Syndrome (ACS), but not within the last 3 months, with any two of the following:
- Typical clinical presentation
- Confirmatory ECG changes
- Appropriate elevation of cardiac enzymes/biomarkers
Previous unstable angina (UA) or Acute Coronary Syndrome (ACS), but not within the last 3 months, with any two of the following:
- Typical clinical presentation
- Confirmatory ECG changes
- Either elevation of a cardiac biomarker or a >50% stenosis in ≥1 major epicardial coronary artery shown on coronary angiography or CT angiography. Where stenosis is reported in a qualitative manner, the categories "moderate" and "severe" will be taken as equating to >50% stenosis.
Current stable angina defined as:
- Typical clinical history with symptoms occurring within the last month, and
- A >50% stenosis in ≥1 major epicardial coronary artery shown on coronary angiography or CT angiography. Where stenosis is reported in a qualitative manner, the categories "moderate" and "severe" will be taken as equating to >50% stenosis.
- Impaired glucose tolerance diagnosed on a single standard oral glucose tolerance test (OGTT) , defined as a 2-hour plasma glucose (2HPG) value ≥7.8 but <11.1 mmol/l and a fasting plasma glucose (FPG) <7.0 mmol/l within six months prior to enrollment.
- Optimised cardiovascular drug therapy.
- At least 80% adherent to single blind placebo Study Medication during the run-in period.
- Provision of written informed consent.
Exclusion Criteria:
- Previous history of diabetes, other than gestational diabetes.
- MI, unstable angina, stroke or a transient ischaemic attack (TIA) within the previous three months.
- Planned or anticipated coronary, cerebrovascular or peripheral arterial revascularisation or other major surgical intervention, at the time of randomisation
- New York Heart Association (NYHA) class III or IV heart failure.
- Evidence of severe hepatic disease.
- Evidence of severe renal impairment or an eGFR <30 ml/min/1.73m2 (derived using the Modification of Diet in Renal Disease, MDRD, Chinese equation)
- Any other condition likely to reduce adherence to the protocol e.g. alcoholism, major active psychiatric disorder, cognitive impairment or a condition likely to markedly limit life expectancy e.g. malignancy.
- Pregnancy (or planned pregnancy within the next five years).
- Concurrent participation in any other clinical interventional trial. Note: Patients who were treated previously with an alphaglucosidase inhibitor must have at least a three-month washout period before being randomised into the ACE trial.
- Known intolerance to alpha glucosidase inhibitors or gastrointestinal problems.
- Thought by the investigator for any reason to be unsuitable for participation in this clinical study.
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Acarbose
The participants were given one tablet (50mg) of acarbose per day, taken with a meal during their first week (7 days).
During the second week, the dose was increased to two tablets/day (50mg twice a day i.e. 100mg/day) and then three tablets/day (50mg three times a day i.e. 150mg/day) thereafter.
The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 150mg/day).
|
The participants were given one tablet (50mg) of acarbose per day, taken with a meal during their first week (7 days).
During the second week, the dose was increased to two tablets/day (50mg twice a day i.e. 100mg/day) and then three tablets/day (50mg three times a day i.e. 150mg/day) thereafter.
The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 150mg/day).
다른 이름들:
|
|
위약 비교기: Matching Placebo
The participants were given one tablet of matching placebo per day, taken with a meal during their first week (7 days).
During the second week, the dose was increased to two tablets/day and then three tablets/day thereafter.
The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 3 tablets/day).
|
The participants were given one tablet of matching placebo per day, taken with a meal during their first week (7 days).
During the second week, the dose was increased to two tablets/day and then three tablets/day thereafter.
The maximum tolerated dose is being taken for the duration of the trial (maximum dose is 3 tablets/day).
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
A composite cardiovascular outcome defined as the time after randomisation to the first occurrence of any one of the following: -Cardiovascular death -Non-fatal MI -Non-fatal stroke -Hospitalisation for Unstable Angina -Hospitalisation for Heart Failure
기간: Follow-up until 728 adjudicated Primary Outcome Measures have been recorded
|
Follow-up until 728 adjudicated Primary Outcome Measures have been recorded
|
2차 결과 측정
결과 측정 |
|---|
|
모든 원인 사망
|
|
Transition to type 2 diabetes confirmed by two successive diagnostic plasma glucose values (FPG >7.0 mmol/l and/or 2HPG > 11.1 mmol/l), with no intervening non-diagnostic values.
|
|
Each of the components of the primary composite cardiovascular outcome will also be analysed individually, both as first and as total events.
|
|
Major Cardiovascular Event (MACE) composite cardiovascular outcome, defined as the time after randomisation to the first occurrence of any one of the following: - Cardiovascular death - Non-fatal MI - Non-fatal stroke
|
|
Impaired renal function as evidenced by: A reduced estimate of glomerular filtration rate( eGFR <30 ml/minute/ 1.73 m2) estimated using the Chinese MDRD formula, a doubling of the baseline plasma creatinine level, a halving of the baseline eGFR
|
|
Resource use, costs and cost effectiveness
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
협력자
수사관
- 수석 연구원: Professor Rury R Holman, FRCP FMedSci, Diabetes Trials Unit, University of Oxford
간행물 및 유용한 링크
연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.
일반 간행물
- Wamil M, McMurray JJV, Scott CAB, Coleman RL, Sun Y, Standl E, Ryden L, Holman RR. Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial. Diabetes Res Clin Pract. 2020 Dec;170:108488. doi: 10.1016/j.diabres.2020.108488. Epub 2020 Oct 6.
- Gerstein HC, Coleman RL, Scott CAB, Xu S, Tuomilehto J, Ryden L, Holman RR; ACE Study Group. Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial. Diabetes Care. 2020 Sep;43(9):2242-2247. doi: 10.2337/dc19-2046. Epub 2020 Jul 8.
- Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ, Ryden L, Schroder S, Sun Y, Theodorakis MJ, Tendera M, Tucker L, Tuomilehto J, Wei Y, Yang W, Wang D, Hu D, Pan C; ACE Study Group. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. doi: 10.1016/S2213-8587(17)30309-1. Epub 2017 Sep 13. Erratum In: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7. Lancet Diabetes Endocrinol. 2019 May;7(5):e5.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
2009년 2월 17일
기본 완료 (실제)
2017년 4월 11일
연구 완료 (실제)
2017년 4월 18일
연구 등록 날짜
최초 제출
2009년 1월 26일
QC 기준을 충족하는 최초 제출
2009년 1월 26일
처음 게시됨 (추정)
2009년 1월 27일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2017년 7월 25일
QC 기준을 충족하는 마지막 업데이트 제출
2017년 7월 21일
마지막으로 확인됨
2017년 7월 1일
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- 11232
- ISRCTN91899513
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
미정
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
관상 동맥 심장 질환에 대한 임상 시험
-
Fondation Hôpital Saint-Joseph모병
-
Chinese Academy of Medical Sciences, Fuwai HospitalMedtronic; CCRF Consulting Co., Ltd.빼는Transradial-transfemoral Coronary Interventions 비교
-
CCRF Consulting Co., Ltd.Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.알려지지 않은심장 또는 뇌혈관 질환 무료 요금 | Transradial-transfemoral Coronary Interventions 비교중국
-
Medical University of BialystokMedical University of Lodz; Poznan University of Medical Sciences; Nicolaus Copernicus University 그리고 다른 협력자들종료됨심부전, 수축기 | 박출률이 감소된 심부전 | 심부전 New York Heart Association Class IV | 심부전 New York Heart Association Class III폴란드
-
Hospital Clinic of BarcelonaAstraZeneca완전한CTO(Chronic Total Occlusion)를 위한 PCI(Percutaneous Coronary Intervention)를 받을 예정인 환자스페인
-
Novartis Pharmaceuticals완전한핵심 연구의 12개월 치료 기간을 성공적으로 완료한 환자(de Novo Heart Recipients)는 EC-MPS 치료에 관심이 있었습니다.
-
University of WashingtonAmerican Heart Association완전한심부전,울혈 | 미토콘드리아 변경 | 심부전 New York Heart Association Class IV미국
-
L2 Bio, LLCFDAMap; Akan Biosciences, Inc.아직 모집하지 않음Crohn & amp;#39; s | Crohn & amp;#39; s Disease (CD)
-
UNC Lineberger Comprehensive Cancer CenterFogarty International Center of the National Institute of Health모집하지 않고 적극적으로
-
Vanderbilt University Medical CenterTakeda Pharmaceuticals U.S.A., Inc.모집하지 않고 적극적으로염증성 장질환(IBD) | 궤양성 대장염(UC) | Crohn & amp;#39; s Disease (CD)미국
Acarbose에 대한 임상 시험
-
Haisco Pharmaceutical Group Co., Ltd.아직 모집하지 않음
-
Astellas Pharma Inc완전한